ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

Hoogstraten Resignation Sidetracks Kansas’ Move to Comprehensive Status, Threatens Core Grant

February 15, 1980

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

Groups Urge FDA To Take Action Against Tobacco Products

June 27, 2014

CCOP RFA On The Street; Addition Of Cancer Control Research Adds New Dimension To Program

July 18, 1986

1985 International Cancer Congress to Be In Budapest

September 24, 1982

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990